mibefradil has been researched along with Rhabdomyolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullingham, R; Gasser, R; Haefeli, WE; Schmassmann-Suhijar, D; Schmutz, J | 1 |
| Jackson, A; McCune, TR; Punn, R; Smith, S; Williams, PB; Wombolt, DG | 1 |
2 other study(ies) available for mibefradil and Rhabdomyolysis
| Article | Year |
|---|---|
Rhabdomyolysis due to interaction of simvastatin with mibefradil.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Benzimidazoles; Calcium Channel Blockers; Drug Interactions; Female; Humans; In Vitro Techniques; Mibefradil; Microsomes, Liver; Rhabdomyolysis; Simvastatin; Tetrahydronaphthalenes | 1998 |
Case report: rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatin.
Topics: Benzimidazoles; Calcium Channel Blockers; Cyclosporine; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Male; Mibefradil; Middle Aged; Rhabdomyolysis; Simvastatin; Tetrahydronaphthalenes | 1999 |